|
|
||||||||
Animal: RNA Viruses |
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA1
Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA2
Author for correspondence: Ronald Montelaro. Fax +1 412 383 8859. e-mail rmont{at}pitt.edu
The genetic variation of equine infectious anaemia virus (EIAV) clearly affects the antigenic properties of the viral envelope; however, effects on immunogenicity remain undefined, although widely assumed. Here, the immunogenicity is reported of a novel, neutralization-resistant, pony-isolate envelope EIAVPV564
PND that contains a 14-residue deletion in the designated principal neutralizing domain (PND) of the gp90 protein. Two ponies inoculated with a chimeric virus, EIAV
PND, containing the EIAVPV564
PND envelope in a reference provirus strain, remained asymptomatic through 14 months post-inoculation, producing high steady-state levels of envelope-specific antibodies but no detectable serum-neutralizing antibodies. Consequent dexamethasone-induced immune suppression produced characteristic EIA that resolved concomitantly with the development of high-titre, strain-specific, neutralizing antibodies and a 100-fold reduction in steady-state virus loads. These results demonstrate: natural variations in the EIAV envelope have profound effects on both antigenic and immunogenic properties; the PND is not required for neutralizing antibody responses; and transient immune suppression can enhance established host immunity to achieve more effective control of steady-state lentivirus replication.
This article has been cited by other articles:
![]() |
J. K. Craigo, B. Zhang, S. Barnes, T. L. Tagmyer, S. J. Cook, C. J. Issel, and R. C. Montelaro Envelope variation as a primary determinant of lentiviral vaccine efficacy PNAS, September 18, 2007; 104(38): 15105 - 15110. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Tagmyer, J. K. Craigo, S. J. Cook, C. J. Issel, and R. C. Montelaro Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus J. Gen. Virol., April 1, 2007; 88(4): 1324 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Craigo, F. Li, J. D. Steckbeck, S. Durkin, L. Howe, S. J. Cook, C. Issel, and R. C. Montelaro Discerning an Effective Balance between Equine Infectious Anemia Virus Attenuation and Vaccine Efficacy J. Virol., March 1, 2005; 79(5): 2666 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Howe, J. K. Craigo, C. J. Issel, and R. C. Montelaro Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain J. Gen. Virol., January 1, 2005; 86(1): 139 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Howe, C. Leroux, C. J. Issel, and R. C. Montelaro Equine Infectious Anemia Virus Envelope Evolution In Vivo during Persistent Infection Progressively Increases Resistance to In Vitro Serum Antibody Neutralization as a Dominant Phenotype J. Virol., October 2, 2002; 76(21): 10588 - 10597. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |